SpaceX (NASDAQ: SPCX) has generated one of the sharpest analyst valuation divides in recent IPO history, with Oppenheimer initiating at $190 while Morningstar values the stock at less than half the offer price.

Key Highlights

  • Oppenheimer initiated SpaceX (NASDAQ: SPCX) with an Outperform rating and a $190 price target, framing the company as the only vertically integrated AI and space platform in public markets.
  • Morningstar valued SpaceX at $63 per share, a discount of more than half to the IPO price, calling the stock significantly overvalued given that even its most optimistic scenario has a single-digit probability weighting.

SpaceX (NASDAQ: SPCX) has attracted one of the widest analyst valuation gaps in recent IPO history, with the most bullish brokerage target implying meaningful upside from the offer price while the most cautious independent assessment sits at a fraction of the listing figure. The divergence reflects fundamentally different frameworks for valuing a company that combines satellite internet, launch services, and artificial intelligence under a single founder-controlled entity.

Oppenheimer became the first major brokerage to initiate coverage of SPCX stock, issuing an Outperform rating with a $190 price target. The analyst framed SpaceX as uniquely positioned among all listed technology companies, arguing that no other publicly traded firm combines proprietary rocket manufacturing, a global satellite internet network, AI model development, and the engineering talent necessary to advance all simultaneously.

New Street Research added a 12-month price target at $165, above the offer price, with the bull case resting on Starlink's structural dominance as the world's largest and lowest-latency satellite internet constellation. The network's position across more than 160 markets creates a recurring revenue base that the most optimistic projections suggest could scale dramatically as enterprise and government contracts expand.

Goldman Sachs projections cited in underwriter models pointed to a potential 100-fold increase in AI-related revenue for SpaceX by 2030, a figure that forms the foundation of the highest valuation scenarios but which independent analysts have characterised as difficult to underwrite with current operational evidence.

Morningstar sits at the opposite end of the spectrum. The research firm assigned a fair value of $63 per share, calling SpaceX significantly overvalued at the IPO price. Notably, Morningstar's most optimistic scenario, which it assigned a probability of less than one-in-ten, generated a fair value of only $154 per share, barely above the listing price.

Valuation professor Aswath Damodaran placed the enterprise value substantially below the IPO implied figure, while short seller Jim Chanos publicly argued that no reasonable five-year projection of revenue and earnings could support the listing valuation. Both bear cases centre on SpaceX trading at approximately 90 times annual revenue, a multiple far exceeding even the most richly valued technology peers.

For investors asking whether SPCX stock is worth buying at the IPO price, the valuation debate ultimately comes down to how much probability one assigns to the most ambitious long-term scenarios involving Starlink global dominance, orbital data centres, and AI revenue growth. That is a judgement call that each investor must make based on their own time horizon and risk tolerance.

This article is for informational purposes only and does not constitute financial advice. Please consult a licensed financial adviser before making investment decisions.